Atlas Trials

Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia

Clinical trial NCT00304447 · COMPLETED

Trial details

NCT number
NCT00304447
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Leukemia, Myelocytic, AcuteInfusions, Intravenous
Start date
2002-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.